Ironwood Pharmaceuticals
Latest round
- Series I
Last raised
- Nov 2009
Total raised
- $283M
Investors
- 17
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, Inc.Founded in 1998 and based in Cambridge, US, Ironwood Pharmaceuticals, Inc. concentrates on gastrointestinal healthcare solutions. The firm has made a significant pivot towards focusing on the commercialization of treatments for GI disorders.00 mn in its IPO and has participated in a total of 9 deals since inception.Ironwood Pharmaceuticals is a prominent player in the gastrointestinal (GI) healthcare sector, dedicated to developing and marketing novel treatments for GI diseases. Its flagship product, LINZESS (linaclotide), launched in 2012, treats irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). LINZESS enhances fluid secretion in the intestines, promoting bowel movements.74 mn. The company's revenue is primarily derived from the sales of prescription medications, particularly LINZESS, through established partnerships with pharmaceutical wholesalers and direct sales to healthcare providers.Ironwood Pharmaceuticals is committed to advancing its product pipeline and expanding its market presence. The company is exploring new treatments for digestive health challenges, with plans to launch additional products in the upcoming years. Ironwood aims to penetrate emerging markets in Europe and Asia by 2025 to broaden access to its GI therapies.
Who invested in Ironwood Pharmaceuticals
17 investors across 8 rounds
See all investors in Ironwood Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series I
Nov 17, 2009
Amount
$15M
Investors
Series G
Oct 1, 2008
Amount
$50M
Investors
Series F
Feb 1, 2007
Amount
$44M
Investors
Series E
Feb 27, 2006
Amount
$75M
Investors
Series D
May 4, 2004
Amount
$40M
Investors
Series C
Apr 1, 2002
Amount
$26M
Investors
Series B
Nov 1, 2000
Amount
$23M
Investors
Series A
Apr 1, 1999
Amount
$9.8M
Investors
Questions about Ironwood Pharmaceuticals
Who invested in Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals has 17 investors on record across 8 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ironwood Pharmaceuticals raised?
Ironwood Pharmaceuticals has raised 8 venture rounds. Sign up free to see how much each round raised and the total.
When did Ironwood Pharmaceuticals last raise money?
Ironwood Pharmaceuticals's most recent round on record is a Series I, in Nov 2009.
What does Ironwood Pharmaceuticals do?
Ironwood Pharmaceuticals is a pharmaceuticals company.
Where is Ironwood Pharmaceuticals headquartered?
Ironwood Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Ironwood Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Ironwood Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series I
Raising like Ironwood Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.